中文

← All funding rounds

Jindu Shengke

ChinaAutonomous labsShenzhen, ChinaPrivate

Pairs a multi-omics model pretrained on individuals' raw sequencing data (GeneLLM, 1.5B parameters by its own account) with BioFord Agent, a set of agents that design experiments and schedule sequencers, liquid handlers, PCR and mass-spec instruments from different vendors.

Disclosed total-
Rounds on record1
Latest roundnearly CNY 100MSeries A · 2026-06-12
Last stated valuationNone stated
Investors named1
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its dateSeries A
Closed roundNot on the dollar scale (a range, or no rate)

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-06-12Series A
    Round

    nearly CNY 100M

    For: R&D on its physics-AI architecture, upgrading the BioFord Agent embodied research platform, and expanding into global markets

    Models and platformAutomated labCommercial roll-out

    36Kr's Guangdong channel reports that the company announced the round, and quotes its founder and CEO, Yongcheng Jin. No other investor, no valuation and no cumulative total are given. No company website was found, so the English name here is the pinyin of the short Chinese name.

    Lead · Gaotejia Investment

    Announced by the company · 36kr.com ↗On the timeline →

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →